Canada markets open in 3 hours 13 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.38+7.70 (+27.82%)
At close: 04:00PM EDT
35.01 -0.37 (-1.05%)
Pre-Market: 06:02AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
217,765
210,762
142,760
121,308
45,200
Selling General and Administrative
48,090
31,400
28,202
28,717
13,447
Total Operating Expenses
265,855
242,162
170,962
150,025
58,647
Operating Income or Loss
-265,855
-242,162
-170,962
-150,025
-58,647
Interest Expense
-
-
-
0
396
Total Other Income/Expenses Net
-694
-1,416
-54
-8
-450
Income Before Tax
-257,399
-235,937
-168,099
-149,291
-59,437
Income from Continuing Operations
-257,399
-235,937
-168,099
-149,291
-59,437
Net Income
-257,399
-235,937
-168,099
-149,291
-59,437
Net Income available to common shareholders
-257,399
-235,937
-168,099
-149,291
-59,437
Basic EPS
-3.59
-
-3.23
-2.93
-4.13
Diluted EPS
-3.59
-
-3.23
-2.93
-4.13
Basic Average Shares
57,538
-
51,976
50,895
14,396
Diluted Average Shares
57,538
-
51,976
50,895
14,396